Tvardi Therapeutics is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases. Founded in 2017 and based in Houston, Texas, the company is led by experienced entrepreneurs, innovative scientists and dedicated physicians.

Biotechnology

Tvardi Therapeutics

Imran Alibhai

John Kauh

Michael Lewis

Joseph Chen, PhD

Jeffrey Larson, PhD, DABT

Riley Gaddy, MBA

Sara Manning

Kari Anne Rowland

Dan Conn

Yixin Chen

Sofia de Achaval

Jeff Larson

Scientific Advisory Board

Leadership Team

Tvardi Therapeutics

Org chart

Teams

Scientific Advisory Board

Leadership Team

Similar companies